The clinically used PARP inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third‐degree burn injury

Publisher: John Wiley & Sons Inc

E-ISSN: 1476-5381|175|2|232-245

ISSN: 0007-1188

Source: BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.175, Iss.2, 2018-01, pp. : 232-245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract